April 8, 2015
Vancouver-based Ayogo has raised $2.5 million from Merck Global Health Innovation Fund (GHI), Excel Venture Management, and 7Wire Ventures for it's patient engagement offering, an app called Empower.
The app, designed for providers and pharma companies, helps patients with chronic conditions stick to their care plans. Patients can use the app to set their own goals, track their health and...
September 30, 2014
Boehringer Ingelheim is a pretty familiar name to people who follow mobile health moves from pharma companies. The large, privately-owned German firm has been involved in pilots with game developer Ayogo, smart pill bottle maker AdhereTech, and now-defunct behavior change platform Healthrageous.
While its partners have talked up these pilots, up until now the company itself has been pretty quiet...
July 9, 2014
AdhereTech's first generation smart pill bottle.
Smart pill bottle maker AdhereTech has raised $1.75 million from undisclosed investors, the company's first non-seed round. CEO Josh Stein told MobiHealthNews the funding is for a very specific need -- redesigning the prototype bottle that AdhereTech has been using in its pilots.
"Basically we’re raising a series A because we want to redesign...
June 27, 2013
Ayogo's Diabestes app for college students.
Health gaming company Ayogo's CEO Michael Fergusson hinted at this week's Games for Health event in Boston that the company is working on a new game for a major pharmaceutical company, although he wasn't able to reveal any details.
"I sure would like to show you this game but I didn't get clearance to show it. We're working with one of the five largest...
June 5, 2013
San Francisco-based digital health accelerator Rock Health announced their fifth class this week. The eleven startups will receive $100,000 in investment and a variety of other perks during their four months in the program.
This class will also be the last one to work out of Rock's old office, in San Francisco's Chinatown. After this class's conclusion, the program will move into new office space...
July 16, 2012
Last week German pharmaceutical company Boehringer Ingelheim announced a deal with Boston-based digital health company Healthrageous, which spun out of Partners Healthcare a few years ago. The companies plan to launch a pilot study to evaluate a lifestyle behavior modification program that aims to help people better manage type II diabetes.
The six-month study will leverage Healthrageous’...